| Product Code: ETC7540905 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The India coronary artery disease therapeutics market import shipment demonstrated remarkable growth with a high CAGR from 2020 to 2024. The market accelerated notably between 2023 and 2024, indicating a strong upward momentum and sustained expansion over the period.
 
                            
                                                    | 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 India Coronary Artery Disease Therapeutics Market Overview | 
| 3.1 India Country Macro Economic Indicators | 
| 3.2 India Coronary Artery Disease Therapeutics Market Revenues & Volume, 2021 & 2031F | 
| 3.3 India Coronary Artery Disease Therapeutics Market - Industry Life Cycle | 
| 3.4 India Coronary Artery Disease Therapeutics Market - Porter's Five Forces | 
| 3.5 India Coronary Artery Disease Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F | 
| 3.6 India Coronary Artery Disease Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F | 
| 4 India Coronary Artery Disease Therapeutics Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.2.1 High prevalence of coronary artery disease in India | 
| 4.2.2 Increasing awareness about the importance of early diagnosis and treatment | 
| 4.2.3 Growing adoption of advanced therapeutics and technologies in healthcare sector | 
| 4.3 Market Restraints | 
| 4.3.1 High cost of coronary artery disease therapeutics | 
| 4.3.2 Limited access to healthcare services, especially in rural areas | 
| 4.3.3 Stringent regulatory requirements for drug approval and market entry | 
| 5 India Coronary Artery Disease Therapeutics Market Trends | 
| 6 India Coronary Artery Disease Therapeutics Market, By Types | 
| 6.1 India Coronary Artery Disease Therapeutics Market, By Drug Class | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Drug Class, 2021- 2031F | 
| 6.1.3 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Statins, 2021- 2031F | 
| 6.1.4 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Beta-blockers, 2021- 2031F | 
| 6.1.5 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Calcium Channel Blockers, 2021- 2031F | 
| 6.1.6 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By ACE Inhibitors, 2021- 2031F | 
| 6.1.7 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Antiplatelet Drugs, 2021- 2031F | 
| 6.1.8 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Others, 2021- 2031F | 
| 6.2 India Coronary Artery Disease Therapeutics Market, By Distribution Channel | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F | 
| 6.2.3 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Online Pharmacies, 2021- 2031F | 
| 6.2.4 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F | 
| 7 India Coronary Artery Disease Therapeutics Market Import-Export Trade Statistics | 
| 7.1 India Coronary Artery Disease Therapeutics Market Export to Major Countries | 
| 7.2 India Coronary Artery Disease Therapeutics Market Imports from Major Countries | 
| 8 India Coronary Artery Disease Therapeutics Market Key Performance Indicators | 
| 8.1 Patient adherence rates to prescribed treatment plans | 
| 8.2 Rate of adoption of new therapeutic interventions | 
| 8.3 Average time taken for diagnosis and initiation of treatment | 
| 9 India Coronary Artery Disease Therapeutics Market - Opportunity Assessment | 
| 9.1 India Coronary Artery Disease Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F | 
| 9.2 India Coronary Artery Disease Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F | 
| 10 India Coronary Artery Disease Therapeutics Market - Competitive Landscape | 
| 10.1 India Coronary Artery Disease Therapeutics Market Revenue Share, By Companies, 2024 | 
| 10.2 India Coronary Artery Disease Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |